Impact of donor and recipient hepatitis C status in lung transplantation
- 1 February 2016
- journal article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 35 (2) , 228-235
Abstract
No abstract availableKeywords
Funding Information
- NIH (U01 HL088942)
This publication has 20 references indexed in Scilit:
- Outcomes After Lung Transplantation and Practices of Lung Transplant Programs in the United States Regarding Hepatitis C Seropositive RecipientsTransplantation, 2011
- Impact of Hepatitis C Infection on Outcomes After Heart TransplantationTransplantation, 2009
- Diagnosis, management, and treatment of hepatitis C: An update # † ‡Hepatology, 2009
- Treatment of Hepatitis C in Potential Lung Transplant CandidatesTransplantation, 2007
- Hepatitis C Virus Antibody Status and Survival After Renal Transplantation: Meta-Analysis of Observational StudiesAmerican Journal of Transplantation, 2005
- Viral hepatitis guidelines in hemodialysis and transplantationAmerican Journal of Transplantation, 2004
- Hepatitis C virus-related fibrosing cholestatic hepatitis after cardiac transplantation: is azathioprine a contributory factor?The Journal of Heart and Lung Transplantation, 1999
- Hepatitis C virus infection and lung transplantation: a survey of practicesThe Journal of Heart and Lung Transplantation, 1999
- INTERNATIONAL GUIDELINES FOR THE SELECTION OF LUNG TRANSPLANT CANDIDATESTransplantation, 1998
- Survival Benefits of Heart and Lung TransplantationAnnals of Surgery, 1996